Electrocardiographic and Cardiac Magnetic Resonance Predictors of Ventricular Arrhythmias in Cardiomyopathic Patients
ECG and CMR for Predicting PVCs in Cardiomyopathic Patients
1 other identifier
observational
79
0 countries
N/A
Brief Summary
This study aims to assess ECG changes for predicting ventricular arrhythmia in cardiomyopathic patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2022
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2021
CompletedFirst Posted
Study publicly available on registry
October 14, 2021
CompletedStudy Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2023
CompletedJanuary 25, 2022
January 1, 2022
9 months
October 2, 2021
January 23, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Twenty-four hours Holter monitoring after Magnetic Resonance Imaging
24 Holter monitoring to detect PVCs burden which is defined as ≥10% of total beats
One year
Interventions
24 hours Holter monitoring
Eligibility Criteria
The study is anticipated to include all consecutive eligible cardiomyopathic patients.
You may qualify if:
- Patients with ischemic and non-ischemic cardiomyopathy, EF \< 40 %
- Patient haemodynamically stable
- Patients accept to make test
You may not qualify if:
- Patients with underlying arrhythmia ex heart block or atrial arrhythmia like PACs, AF.
- Patients on arrhythmogenic drugs ex digitalis, amiodarone.
- Patients on underlying Pacemaker device or CRT-D.
- Patients with MI in less than 40 days
- Patients refuse to make test .
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Mathew T, Williams L, Navaratnam G, Rana B, Wheeler R, Collins K, Harkness A, Jones R, Knight D, O'Gallagher K, Oxborough D, Ring L, Sandoval J, Stout M, Sharma V, Steeds RP; British Society of Echocardiography Education Committee. Diagnosis and assessment of dilated cardiomyopathy: a guideline protocol from the British Society of Echocardiography. Echo Res Pract. 2017 Jun;4(2):G1-G13. doi: 10.1530/ERP-16-0037.
PMID: 28592613RESULTPinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, Duboc D, Gimeno J, de Groote P, Imazio M, Heymans S, Klingel K, Komajda M, Limongelli G, Linhart A, Mogensen J, Moon J, Pieper PG, Seferovic PM, Schueler S, Zamorano JL, Caforio AL, Charron P. Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 2016 Jun 14;37(23):1850-8. doi: 10.1093/eurheartj/ehv727. Epub 2016 Jan 19.
PMID: 26792875RESULTSharma E, Arunachalam K, Di M, Chu A, Maan A. PVCs, PVC-Induced Cardiomyopathy, and the Role of Catheter Ablation. Crit Pathw Cardiol. 2017 Jun;16(2):76-80. doi: 10.1097/HPC.0000000000000106.
PMID: 28509708RESULTLee DC, Markl M, Dall'Armellina E, Han Y, Kozerke S, Kuehne T, Nielles-Vallespin S, Messroghli D, Patel A, Schaeffter T, Simonetti O, Valente AM, Weinsaft JW, Wright G, Zimmerman S, Schulz-Menger J. The growth and evolution of cardiovascular magnetic resonance: a 20-year history of the Society for Cardiovascular Magnetic Resonance (SCMR) annual scientific sessions. J Cardiovasc Magn Reson. 2018 Jan 31;20(1):8. doi: 10.1186/s12968-018-0429-z.
PMID: 29386064RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident doctor of cardiology .Luxor International Hospital
Study Record Dates
First Submitted
October 2, 2021
First Posted
October 14, 2021
Study Start
April 1, 2022
Primary Completion
December 31, 2022
Study Completion
March 30, 2023
Last Updated
January 25, 2022
Record last verified: 2022-01